麦迪科技三季报：聚焦医疗主业 经营质量稳步提升

Core Insights - The company reported significant improvement in its financial performance for the first three quarters of 2025, achieving a revenue of 223 million yuan and a net profit of 34.27 million yuan, marking a substantial turnaround from losses in the same period last year [1] - The company has successfully completed the divestiture of its photovoltaic business and refocused on its core medical operations, demonstrating the effectiveness of its strategic pivot [1] - The company has made notable advancements in the field of domestic software adaptation and innovation, ensuring compatibility with major domestic hardware and software platforms, which aligns with national technology requirements [1] Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 223 million yuan and a net profit of 34.27 million yuan, indicating a significant recovery compared to the previous year's losses [1] Strategic Developments - The company has completed the localization and adaptation of critical software for severe illness management, ensuring deep compatibility with mainstream domestic hardware and software platforms [1] - The company participated in the launch of the Global Education Healthcare Partners Alliance (GEHPA) initiated by Huawei, which includes industry leaders from over 40 countries, aimed at driving innovation and shared opportunities in the education and healthcare sectors [2] Technological Advancements - The company has established a comprehensive ecosystem in the smart healthcare sector, collaborating with partners like Huawei to develop a task-driven intelligent platform for elderly care, integrating computing power, large models, robotics, and data collection [2] - The company is positioned as a supplier of comprehensive smart healthcare solutions and a developer of real application scenarios, leveraging over 20 years of experience in medical information technology [2] Future Outlook - The management has expressed a commitment to deepen its focus on the medical sector, aiming to enhance its competitive advantage through ongoing technological research and product optimization for sustainable development [3]